Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Rheumatology|April 3, 2026
Development of a machine learning-based nomogram for predicting atherosclerosis risk in patients with systemic lupus erythematosusChengyi He, Siyu Feng, Yuanbin Zhang, et al.
International Journal of Pharmaceutics|December 20, 2005
Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug deliveryChaoyang Wang, Chengyi He, Zhen Tong, et al.
Plos One|December 4, 2025
Comparative effectiveness of adjuvant treatment for hepatocellular carcinoma with high risk of recurrence: A systematic review and network meta-analysisZha Peng, Leigu Shen, Yaqiong Wang, et al.
Frontiers in Oncology|December 18, 2025
Clinical efficacy of hepatic arterial infusion chemotherapy combined with transhepatic arterial embolization plus lenvatinib and tislelizumab or transarterial chemoembolization combined with lenvatinib plus tislelizumab in the treatment of advanced hepatocellular carcinomaZha Peng, Yaqiong Wang, Boyu Chen, et al.
Frontiers in Medicine|May 13, 2025
DNA methylation-driven genes in hepatocellular carcinoma patients: insights into immune infiltration and prognostic implicationsZhi Zhang, Tongling Zhao, Weida Meng, et al.
Biomedicines|July 27, 2024
Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of AtherosclerosisQiushuo Zong, Chengyi He, Binbin Long, et al.
Plos One|August 8, 2014
Human umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse modelRuiping Zhou, Zhuokun Li, Chengyi He, et al.
Scientific Reports|June 10, 2015
Antioxidant treatment enhances human mesenchymal stem cell anti-stress ability and therapeutic efficacy in an acute liver failure modelWen Zeng, Jia Xiao, Gang Zheng, et al.
Frontiers in Pharmacology|January 20, 2025
Dihydromyricetin: an emerging compound with comprehensive effects on multiple systemsChengyi He, Yunfei Chen, Jiao Xie, et al.
International Immunopharmacology|October 18, 2024
Corilagin inhibits human cytomegalovirus infection and replication via activating the cGAS-STING signaling pathway in vitro and in vivoJiao Xie, Luorui Shang, Cuiling Liu, et al.
Pageof 2